Seretide/Advair
Ailment: Asthma
U.S. Sales: $3.2 billion
Owner: GlaxoSmithKline
Millions of patients take Advair to control the symptoms of asthma, one of the most common diseases worldwide. Despite its wide success and use, some critics worry that patients are using the drug inappropriately, increasing the risk of serious side effects.
